Clinical Trials Directory

Trials / Completed

CompletedNCT06053437

Prognostic Indicators in Pituitary Adenoma Surgery: a Comprehensive Analysis of Surgical Outcomes and Complications.

Status
Completed
Phase
Study type
Observational
Enrollment
211 (actual)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Predicting the outcome of pituitary surgery, particularly the risk of complications, is a critical determinant in selecting the appropriate treatment modality for patients. To date, only a limited number of risk factors have been identified for complications following pituitary surgery, including tumor size, younger age, and previous surgical intervention. Furthermore, existing studies have demonstrated that prolactin levels can serve as a surrogate marker for assessing pituitary function, specifically revealing associations between elevated prolactin levels and anterior pituitary insufficiencies. In a retrospective study on the "HYP'OP" cohort, the aim of the study is to identify predictive factors for both surgical outcomes and complications.

Conditions

Timeline

Start date
2023-02-01
Primary completion
2023-07-15
Completion
2023-09-01
First posted
2023-09-25
Last updated
2023-09-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06053437. Inclusion in this directory is not an endorsement.